Decreased beta-phenylethylamine in CSF in Parkinson's disease.
about
Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.Plasma Biomarkers for Monitoring Brain Pathophysiology in FMR1 Premutation Carriers.Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy
P2860
Decreased beta-phenylethylamine in CSF in Parkinson's disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Decreased beta-phenylethylamine in CSF in Parkinson's disease.
@ast
Decreased beta-phenylethylamine in CSF in Parkinson's disease.
@en
type
label
Decreased beta-phenylethylamine in CSF in Parkinson's disease.
@ast
Decreased beta-phenylethylamine in CSF in Parkinson's disease.
@en
altLabel
Decreased beta -phenylethylamine in CSF in Parkinson's disease
@en
prefLabel
Decreased beta-phenylethylamine in CSF in Parkinson's disease.
@ast
Decreased beta-phenylethylamine in CSF in Parkinson's disease.
@en
P2093
P2860
P356
P1476
Decreased beta-phenylethylamine in CSF in Parkinson's disease.
@en
P2093
P2860
P304
P356
10.1136/JNNP.63.6.754
P407
P577
1997-12-01T00:00:00Z